MEI’s valuation metrics: A comprehensive analysis

Methode Electronics, Inc (MEI)’s stock has witnessed a price declined of -21.77% from the previous close with its current price standing at $8.05. Its current price is -53.87% under its 52-week high of $17.45 and 58.36% more than its 52-week low of $5.08. Based on the past 30-day period, the stock price is -24.64% below the high and +1.50% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, MEI’s SMA-200 is $9.47.

Additionally, it is important to take into account MEI stock ratios, including its price-to-sales ratio, which is 0.27 for the last tewlve months.MEI’s price to book ratio for the most recent quarter was 0.42, resulting in an 2.77 price to cash per share for the period.

How does Methode Electronics, Inc (MEI) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 3 brokerage firms that recommend the stock as a Moderate Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 3.67 in simple terms.

Methode Electronics, Inc (MEI): Earnings History

If we examine Methode Electronics, Inc’s recent earnings history, in the last quarter ended on 1/31/2025, it posted adjusted earnings per share of -$0.21, beating the consensus of -$0.08. In other words, it beat the consensus by -$0.14, resulting in a -180.00% surprise. In the 3 months period before the previous quarter which was closed on 1/31/2025, the stock recorded adjusted earnings per share of -$0.21 in contrast with the Outlook of -$0.08. That was a difference of -$0.14 and a surprise of -180.00%.

Methode Electronics, Inc (NYSE: MEI) Ownership Details

I will give a breakdown of the key shareholders in Methode Electronics, Inc (MEI). Recent figures show that the company’s insiders hold 6.11% of shares. A total of 215 institutional investors hold shares in the company, making 91.59% of its stock and 97.54% of its float.

Mar 31, 2025 , it was reported that the Company’s largest institutional holder is FMR, LLC holding total of 5.23 shares that make 14.66% of the company’s total number of shares and are currently priced at 41.22 million.

The securities firm Blackrock Inc. holds 4.11 shares of MEI, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 11.51% , and the holding percentage of shares is valued at 32.36 million.

An overview of Methode Electronics, Inc’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Methode Electronics, Inc (MEI) traded 331,419 shares per day, with a moving average of $9.39 and price change of -0.56. With the moving average of $8.24 and a price change of +1.71, about 279,375 shares changed hands on average over the past 50 days. Finally, MEI’s 100-day average volume is 373,641 shares, alongside a moving average of $7.80 and a price change of -2.44.

Hot this week

Should investors be concerned about Centuri Holdings Inc (CTRI)?

While Centuri Holdings Inc has underperformed by -0.41%, investors...

Is eXp World Holdings Inc (EXPI) worth investing in despite its overvalued state?

While eXp World Holdings Inc has overperformed by 5.23%,...

Are MoonLake Immunotherapeutics (MLTX) shares a good deal now?

While MoonLake Immunotherapeutics has overperformed by 1.24%, investors are...

Tarsus Pharmaceuticals Inc (TARS) requires closer examination

While Tarsus Pharmaceuticals Inc has underperformed by -0.31%, investors...

Warrior Met Coal Inc (HCC) shows promising results

While Warrior Met Coal Inc has overperformed by 4.47%,...

Topics

Should investors be concerned about Centuri Holdings Inc (CTRI)?

While Centuri Holdings Inc has underperformed by -0.41%, investors...

Is eXp World Holdings Inc (EXPI) worth investing in despite its overvalued state?

While eXp World Holdings Inc has overperformed by 5.23%,...

Are MoonLake Immunotherapeutics (MLTX) shares a good deal now?

While MoonLake Immunotherapeutics has overperformed by 1.24%, investors are...

Tarsus Pharmaceuticals Inc (TARS) requires closer examination

While Tarsus Pharmaceuticals Inc has underperformed by -0.31%, investors...

Warrior Met Coal Inc (HCC) shows promising results

While Warrior Met Coal Inc has overperformed by 4.47%,...

What was Airsculpt Technologies Inc (AIRS)’s performance in the last session?

Within its last year performance, AIRS fell by -3.85%,...

Is Ionis Pharmaceuticals Inc (IONS) a good investment opportunity?

While Ionis Pharmaceuticals Inc has underperformed by -1.05%, investors...

Icon Plc (ICLR) presents a great opportunity, but the stock is slightly overvalued

While Icon Plc has overperformed by 1.02%, investors are...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.